NASDAQ:RXRX | Income Statement | RECURSION PHARMACEUTICALS, INC.

Complete source-backed income-statement history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$7.67M$11.49M$89.61M-$134.97M$3.96M-$131.01M-$1,000.00-$131.01M-$0.25-$0.25532,460,085532,460,085
2026-03-31$6.47M$12.49M$87.9M-$128.51M$6.4M-$122.11M-$4.6M-$117.5M-$0.22-$0.22529,303,984529,303,984
2025-12-31$35.54M$14.28M$95.94M-$108.33M$232,000.00-$108.1M$20,000.00-$108.12M-$0.17-$0.1724,803,45624,803,456
2025-09-30$5.18M$14.69M$121.06M-$172.2M$9.95M-$162.25M$3,000.00-$162.25M-$0.36-$0.36446,988,046446,988,046
2025-06-30$19.22M$20.16M$128.64M-$176.23M$4.33M-$171.9M$0.00-$171.9M-$0.41-$0.41417,361,147417,361,147
2025-03-31$14.75M$21.83M$129.63M-$191.37M-$11.28M-$202.65M-$158,000.00-$202.49M-$0.50-$0.50402,771,972402,771,972
2024-12-31$4.55M$12.79M$98.33M-$183.77M$4.87M-$178.9M$7,000.00-$178.91M-$0.57-$0.5720,760,04720,760,047
2024-09-30$26.08M$12.08M$74.6M-$98.35M$2.68M-$95.68M$167,000.00-$95.84M-$0.34-$0.34282,583,048282,583,048
2024-06-30$14.42M$9.2M$73.93M-$100.54M$2.48M-$98.06M-$523,000.00-$97.54M-$0.40-$0.40242,196,409242,196,409
2024-03-31$13.79M$11.17M$67.56M-$96.34M$4.19M-$92.15M-$779,000.00-$91.37M-$0.39-$0.39236,019,349236,019,349
2023-12-31$10.89M$9.88M$69.48M-$98.93M$1.87M-$97.06M-$4.06M-$93M-$0.42-$0.424,763,0654,763,065
2023-09-30$10.53M$10.88M$70.01M-$99.55M$6.53M-$93.02M$0.00-$93.02M-$0.43-$0.43214,327,186214,327,186
2023-06-30$11.02M$9.38M$55.06M-$81.72M$4.99M-$76.73M$0.00-$76.73M-$0.38-$0.38201,415,475201,415,475
2023-03-31$12.13M$12.45M$46.68M-$69.87M$4.54M-$65.33M$0.00-$65.33M-$0.34-$0.34191,618,238191,618,238
2022-12-31$13.68M$10.84M$43.98M-$60.98M$3.49M$0.00-$57.49M-$0.30-$0.303,414,5133,414,513
2022-09-30$13.16M$15.41M$40.84M-$62.57M$2.13M$0.00-$60.45M-$0.35-$0.35173,435,970173,435,970
2022-06-30$7.67M$14.23M$38.44M-$66.19M$631,000.00$0.00-$65.56M-$0.38-$0.38172,212,390172,212,390
2022-03-31$5.33M$7.8M$32.44M-$55.98M$2,000.00$0.00-$55.98M-$0.33-$0.33170,690,392170,690,392
2021-12-31$2.53M$0.00$48.29M$67.49M-$64.96M$27,000.00$0.00-$64.93M-$0.39-$0.3914,834,87914,834,879
2021-09-30$2.53M$0.00$33.25M$48.94M-$46.4M-$1.03M$0.00-$47.43M-$0.28-$0.28168,533,550168,533,550
2021-06-30$2.55M$0.00$29.62M$43.48M-$40.93M-$2.47M$0.00-$43.4M-$0.31-$0.31138,360,646138,360,646
2021-03-31$2.56M$0.00$24.11M$33.05M-$30.48M-$233,000.00$0.00-$30.72M-$1.33-$1.3323,035,62323,035,623
2020-12-31$2.69M$20.7M$28.27M-$25.58M-$185,000.00$0.00-$25.77M-$1.17-$1.1777,37877,378
2020-09-30$1.03M$16.54M$23.5M-$22.47M-$1.4M$0.00-$23.87M-$1.09-$1.0921,817,90021,817,900
2020-06-30$186,000.00$13.24M$18.4M-$18.22M-$726,000.00$0.00-$18.94M-$0.88-$0.8821,652,27721,652,277
2020-03-31$60,000.00$12.84M$18.4M-$18.34M-$81,000.00$0.00-$18.42M-$0.85-$0.8521,639,89121,639,891

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$74.68M$70.95M$475.27M-$648.13M$3.24M-$644.9M-$136,000.00-$644.76M-$1.44-$1.44447,446,109447,446,109
2024-12-31$58.84M$45.24M$314.42M-$479M$14.22M-$464.79M-$1.13M-$463.66M-$1.69-$1.69274,207,146274,207,146
2023-12-31$44.58M$42.59M$241.23M-$350.06M$17.93M-$332.13M-$4.06M-$328.07M-$1.58-$1.58207,853,702207,853,702
2022-12-31$39.84M$48.28M$155.7M-$245.73M$6.25M-$239.48M$0.00-$239.48M-$1.36-$1.36175,537,487175,537,487
2021-12-31$10.18M$0.00$135.27M$192.95M-$182.78M-$3.7M-$186.48M$0.00-$186.48M-$1.49-$1.49125,348,110125,348,110
2020-12-31$3.96M$0.00$63.32M$88.58M-$84.62M-$2.39M$0.00-$87.01M-$3.99-$3.9921,781,38621,781,386
2019-12-31$2.32M$45.81M$64.76M-$62.44M$562,000.00$0.00-$61.88M-$2.87-$2.8721,570,26521,570,265

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.